author-photo

Roy S. Herbst

Yale University
University of Texas MD Anderson Cancer Center
Yale Cancer Center

736

Papers

48576

Citations

Citation Trend

Filter By

Papers (736) Sort By

Journal Conference Others

Phase II randomized study of ramucirumab plus pembrolizumab versus standard of care for advanced non-small cell lung cancer previously treated with a checkpoint inhibitor: Toxicity update (Lung-MAP non-matched sub-study S1800A)

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN).

2021 Organic Process Research & Development
Show All
- Source
- Cite
- Save
Citations (0)
P01.21 ANSELMA: Antiangiogenic Second Line Lung Cancer Meta-Analysis on Individual Patient Data in Non-Small Cell Lung Cancer, Again Relevant in ICI Era

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (0)
FP13.01 5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (3)
The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PO-078: Exploring adversarial image attacks on deep learning models in oncology

2021
Show All
- Source
- Cite
- Save
Citations (0)
OA06.03 Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (2)